{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:44:48Z","timestamp":1791092688473,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>17alpha-hydroxylase\/17, 20-lyase encoded by CYP17 is the key enzyme in androgen biosynthesis pathway. Previous studies demonstrated the accentuation of the enzyme in patients with polycystic ovary syndrome (PCOS) was the most important mechanism of androgen excess. We chose CYP17 as the therapeutic target, trying to suppress the activity of 17alpha-hydroxylase\/17, 20-lyase and inhibit androgen biosynthesis by silencing the expression of CYP17 in the rat ovary.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Three CYP17-targeting and one negative control oligonucleotides were designed and used in the present study. The silence efficiency of lentivirus shRNA was assessed by qRT-PCR, Western blotting and hormone assay. After subcapsular injection of lentivirus shRNA in rat ovary, the delivery efficiency was evaluated by GFP fluorescence and qPCR. Total RNA was extracted from rat ovary for CYP17 mRNA determination and rat serum was collected for hormone measurement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In total, three CYP17-targeting lentivirus shRNAs were synthesized. The results showed that all of them had a silencing effect on CYP17 mRNA and protein. Moreover, androstenedione secreted by rat theca interstitial cells (TIC) in the RNAi group declined significantly compared with that in the control group. Two weeks after rat ovarian subcapsular injection of chosen CYP17 shRNA, the GFP fluorescence of frozen ovarian sections could be seen clearly under fluorescence microscope. It also showed that the GFP DNA level increased significantly, and its relative expression level was 7.42 times higher than that in the control group. Simultaneously, shRNA treatment significantly decreased CYP17 mRNA and protein levels at 61% and 54%, respectively. Hormone assay showed that all the levels of androstenedione, 17-hydroxyprogesterone and testosterone declined to a certain degree, but progesterone levels declined significantly.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The present study proves for the first time that ovarian androgen biosynthesis can be inhibited by silencing CYP17 expression. It may provide a novel strategy for therapy of hyperandrogenism diseases, and also set an example for the use of RNAi technology in endocrine diseases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7827-7-73","type":"journal-article","created":{"date-parts":[[2009,7,18]],"date-time":"2009-07-18T07:43:17Z","timestamp":1247902997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Study of RNA interference inhibiting rat ovarian androgen biosynthesis by depressing 17alpha-hydroxylase\/17, 20-lyase activity in vivo"],"prefix":"10.1186","volume":"7","author":[{"given":"Yi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-na","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-lao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-gan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,17]]},"reference":[{"key":"545_CR1","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF: Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006, 91: 4237-4245. 10.1210\/jc.2006-0178.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1210\/jc.2005-1457","volume":"91","author":"E Carmina","year":"2006","unstructured":"Carmina E, Rosato F, Janni A, Rizzo M, Longo RA: Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab. 2006, 91: 2-6. 10.1210\/jc.2005-1457.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1210\/jc.2003-031122","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR: Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004, 89: 453-462. 10.1210\/jc.2003-031122.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/humupd\/dmh010","volume":"10","author":"S Jonard","year":"2004","unstructured":"Jonard S, Dewailly D: The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update. 2004, 10: 107-117. 10.1093\/humupd\/dmh010.","journal-title":"Hum Reprod Update"},{"key":"545_CR5","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1210\/jc.85.3.1206","volume":"85","author":"JR Eisner","year":"2000","unstructured":"Eisner JR, Dumesic DA, Kemnitz JW, Abbott DH: Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. J Clin Endocrinol Metab. 2000, 85: 1206-1210. 10.1210\/jc.85.3.1206.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR6","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.1210\/jc.2004-0918","volume":"89","author":"CM Bruns","year":"2004","unstructured":"Bruns CM, Baum ST, Colman RJ, Eisner JR, Kemnitz JW, Weindruch R, Abbott DH: Insulin resistance and impaired insulin secretion in prenatally androgenized male rhesus monkeys. J Clin Endocrinol Metab. 2004, 89: 6218-6223. 10.1210\/jc.2004-0918.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR7","first-page":"2","volume":"69","author":"WA van Vloten","year":"2002","unstructured":"van Vloten WA, van Haselen CW, van Zuuren EJ, Gerlinger C, Heithecker R: The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea. Cutis. 2002, 69: 2-15.","journal-title":"Cutis"},{"key":"545_CR8","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(03)13493-9","volume":"361","author":"L Harborne","year":"2003","unstructured":"Harborne L, Fleming R, Lyall H, Norman J, Sattar N: Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet. 2003, 361: 1894-1901. 10.1016\/S0140-6736(03)13493-9.","journal-title":"Lancet"},{"key":"545_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1056\/NEJM198903023200904","volume":"320","author":"RB Barnes","year":"1989","unstructured":"Barnes RB, Rosenfield RL, Burstein S, Ehrmann DA: Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 1989, 320: 559-565.","journal-title":"N Engl J Med"},{"key":"545_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1056\/NEJM199207163270304","volume":"327","author":"DA Ehrmann","year":"1992","unstructured":"Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z: Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 1992, 327: 157-162.","journal-title":"N Engl J Med"},{"key":"545_CR11","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1210\/mend.13.6.0311","volume":"13","author":"VL Nelson","year":"1999","unstructured":"Nelson VL, Legro RS, Strauss JR, McAllister JM: Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol. 1999, 13: 946-957. 10.1210\/me.13.6.946.","journal-title":"Mol Endocrinol"},{"key":"545_CR12","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1210\/jcem.86.12.8088","volume":"86","author":"VL Nelson","year":"2001","unstructured":"Nelson VL, Qin KN, Rosenfield RL, Wood JR, Penning TM, Legro RS, Strauss JR, McAllister JM: The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001, 86: 5925-5933. 10.1210\/jc.86.12.5925.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR13","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1158\/0008-5472.CAN-04-3981","volume":"65","author":"T Hata","year":"2005","unstructured":"Hata T, Furukawa T, Sunamura M, Egawa S, Motoi F, Ohmura N, Marumoto T, Saya H, Horii A: RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. Cancer Res. 2005, 65: 2899-2905. 10.1158\/0008-5472.CAN-04-3981.","journal-title":"Cancer Res"},{"key":"545_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canlet.2004.10.019","volume":"223","author":"S Yanamoto","year":"2005","unstructured":"Yanamoto S, Iwamoto T, Kawasaki G, Yoshitomi I, Baba N, Mizuno A: Silencing of the p53R2 gene by RNA interference inhibits growth and enhances 5-fluorouracil sensitivity of oral cancer cells. Cancer Lett. 2005, 223: 67-76. 10.1016\/j.canlet.2004.10.019.","journal-title":"Cancer Lett"},{"key":"545_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nm828","volume":"9","author":"E Song","year":"2003","unstructured":"Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J, Chen J, Shankar P, Lieberman J: RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med. 2003, 9: 347-351. 10.1038\/nm828.","journal-title":"Nat Med"},{"key":"545_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/418038a","volume":"418","author":"AP McCaffrey","year":"2002","unstructured":"McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA: RNA interference in adult mice. Nature. 2002, 418: 38-39. 10.1038\/418038a.","journal-title":"Nature"},{"key":"545_CR17","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nbt824","volume":"21","author":"AP McCaffrey","year":"2003","unstructured":"McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, Xu H, Wieland SF, Marion PL, Kay MA: Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol. 2003, 21: 639-644. 10.1038\/nbt824.","journal-title":"Nat Biotechnol"},{"key":"545_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm1205","volume":"11","author":"GS Ralph","year":"2005","unstructured":"Ralph GS, Radcliffe PA, Day DM, Carthy JM, Leroux MA, Lee DC, Wong LF, Bilsland LG, Greensmith L, Kingsman SM, Mitrophanous KA, Mazarakis ND, Azzouz M: Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat Med. 2005, 11: 429-433. 10.1038\/nm1205.","journal-title":"Nat Med"},{"key":"545_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nm1207","volume":"11","author":"C Raoul","year":"2005","unstructured":"Raoul C, Abbas-Terki T, Bensadoun JC, Guillot S, Haase G, Szulc J, Henderson CE, Aebischer P: Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med. 2005, 11: 423-428. 10.1038\/nm1207.","journal-title":"Nat Med"},{"key":"545_CR20","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper SQ, Staber PD, He X, Eliason SL, Martins IH, Mao Q, Yang L, Kotin RM, Paulson HL, Davidson BL: RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc Natl Acad Sci USA. 2005, 102: 5820-5825. 10.1073\/pnas.0501507102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"545_CR21","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1210\/endo-122-5-2345","volume":"122","author":"DA Magoffin","year":"1988","unstructured":"Magoffin DA, Erickson GF: Purification of ovarian theca-interstitial cells by density gradient centrifugation. Endocrinology. 1988, 122: 2345-2347.","journal-title":"Endocrinology"},{"key":"545_CR22","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1210\/jc.85.6.2304","volume":"85","author":"JK Wickenheisser","year":"2000","unstructured":"Wickenheisser JK, Quinn PG, Nelson VL, Legro RS, Strauss JR, McAllister JM: Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells. J Clin Endocrinol Metab. 2000, 85: 2304-2311. 10.1210\/jc.85.6.2304.","journal-title":"J Clin Endocrinol Metab"},{"key":"545_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cellbi.2007.12.011","volume":"32","author":"J Du","year":"2008","unstructured":"Du J, Liang X, Zeng H, Shu Y, Yao S, Zhu B, Zhuang G: Effect of small interfering RNAs of cytochrome P450 17alpha-hydroxylase\/17,20-lyase (CYP17) on androgen biosynthesis in theca cells. Cell Biol Int. 2008, 32: 469-472. 10.1016\/j.cellbi.2007.12.011.","journal-title":"Cell Biol Int"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7827-7-73.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T08:22:07Z","timestamp":1630484527000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/1477-7827-7-73"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,17]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["545"],"URL":"https:\/\/doi.org\/10.1186\/1477-7827-7-73","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,17]]},"assertion":[{"value":"21 April 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"73"}}